Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 3, 2007, Pages 528-534

  Curnow, J L ^a,b   Morel Kopp, M C ^a,b   Roddie, C ^a   Aboud, M ^b,c   Ward, Christopher M ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c Pacific Laboratory Medicine Services   (Australia)

Author keywords

Antiphospholipid antibodies; Fibrin generation; Fibrinolysis; Global coagulation assay; Hypercoagulable states

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING TEST; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HEALTH CARE COST; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OVERALL HEMOSTATIC POTENTIAL ASSAY; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THROMBOSIS; VENOUS THROMBOEMBOLISM; ADOLESCENT; AGED; BLOOD; CASE CONTROL STUDY; HEMOSTASIS; METABOLISM; METHODOLOGY; MIDDLE AGED; PILOT STUDY; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY COMPLICATION; REPRODUCIBILITY; THROMBOEMBOLISM; THROMBOPHILIA; TIME; VEIN THROMBOSIS;

FIBRIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; FIBRIN; FIBRINOLYSIS; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM; THROMBOPHILIA; TIME FACTORS; VENOUS THROMBOSIS;

EID: 34247554940     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02362.x     Document Type: Article

References (16)

1. He S, Bremme K, Blombäck M. A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results. Thromb Res 1999; 96: 145.
2. He S, Antovic A, Blombäck M. A simple and rapid laboratory method for determination of hemostasis potential in plasma II. Modifications for use in routine laboratories and research work. Thromb Res 2001; 103: 355-61.
3. Whiteman T, Hassouna HI. Hypercoagulable states. Hematol Oncol Clin North Am 2000; 14: 355-77.
4. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63.
5. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000; 15: 145-51.
6. Monroe D, Hoffman M, Roberts H. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22: 1381-9.
7. Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
8. Hemker HC, Beguin S. Thrombin generation in plasma: Its assessment via the endogenous thrombin potential. Thromb Haemost 1995; 74: 134-8.
9. Wielders S, Mukherjee M, Michiels J, Rijkers DT, Cambus JP, Knebel RW, Kakkar V, Hemker HC, Béguin S. The routine determination of the endogenous thrombin potential, first results in different forms of hyper-and hypocoagulability. Thromb Haemost 1997; 77: 629-36.
10. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Beguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000; 83: 589-91.
11. Andresen MS, Iversen N, Abildgaard U. Overall haemostasis potential assays performed in thrombophilic plasma: The effect of preactivating protein C and antithrombin. Thromb Res 2002; 108: 323-8.
12. Eichinger S, Weltermann A, Philipp K, Hafner E, Kaider A, Kittl EM, Brenner B, Mannhalter C, Lechner K, Kyrle PA. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999; 82: 1232-6.
13. Regnault V, Beguin S, Lecompte T. Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability. Pathophysiol Haemost Thromb 2003; 33: 23-9.
14. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004; 104: 3631-4.
15. Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA. Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost 2003; 4: 752-6.
16. Tripodi A, Mannucci PM. Activated partial thromboplastin time (APTT). New indications for an old test? J Thromb Haemost 2006; 4: 750-1.